OBJECTIVE: Demyelination that results from disease or traumatic injury, such as spinal cord injury (SCI), can have a devastating effect on neural function and recovery. Many researchers are examining treatments to minimize demyelination by improving oligodendrocyte availability in vivo. Transplantation of stem and oligodendrocyte progenitor cells is a promising option, however, trials are plagued by undirected differentiation. Here we introduce a biomaterial that has been optimized to direct the differentiation of neural progenitor cells (NPCs) toward oligodendrocytes as a cell delivery vehicle after SCI. APPROACH: A collagen-based hydrogel was modified to mimic the mechanical properties of the neonatal spinal cord, and components present in the developing extracellular matrix were included to provide appropriate chemical cues to the NPCs to direct their differentiation toward oligodendrocytes. The hydrogel with cells was then transplanted into a unilateral cervical contusion model of SCI to examine the functional recovery with this treatment. Six behavioral tests and histological assessment were performed to examine the in vivo response to this treatment. MAIN RESULTS: Our results demonstrate that we can achieve a significant increase in oligodendrocyte differentiation of NPCs compared to standard culture conditions using a three-component biomaterial composed of collagen, hyaluronic acid, and laminin that has mechanical properties matched to those of neonatal neural tissue. Additionally, SCI rats with hydrogel transplants, with and without NPCs, showed functional recovery. Animals transplanted with hydrogels with NPCs showed significantly increased functional recovery over six weeks compared to the media control group. SIGNIFICANCE: The three-component hydrogel presented here has the potential to provide cues to direct differentiation in vivo to encourage regeneration of the central nervous system.
OBJECTIVE:Demyelination that results from disease or traumatic injury, such as spinal cord injury (SCI), can have a devastating effect on neural function and recovery. Many researchers are examining treatments to minimize demyelination by improving oligodendrocyte availability in vivo. Transplantation of stem and oligodendrocyte progenitor cells is a promising option, however, trials are plagued by undirected differentiation. Here we introduce a biomaterial that has been optimized to direct the differentiation of neural progenitor cells (NPCs) toward oligodendrocytes as a cell delivery vehicle after SCI. APPROACH: A collagen-based hydrogel was modified to mimic the mechanical properties of the neonatal spinal cord, and components present in the developing extracellular matrix were included to provide appropriate chemical cues to the NPCs to direct their differentiation toward oligodendrocytes. The hydrogel with cells was then transplanted into a unilateral cervical contusion model of SCI to examine the functional recovery with this treatment. Six behavioral tests and histological assessment were performed to examine the in vivo response to this treatment. MAIN RESULTS: Our results demonstrate that we can achieve a significant increase in oligodendrocyte differentiation of NPCs compared to standard culture conditions using a three-component biomaterial composed of collagen, hyaluronic acid, and laminin that has mechanical properties matched to those of neonatal neural tissue. Additionally, SCI rats with hydrogel transplants, with and without NPCs, showed functional recovery. Animals transplanted with hydrogels with NPCs showed significantly increased functional recovery over six weeks compared to the media control group. SIGNIFICANCE: The three-component hydrogel presented here has the potential to provide cues to direct differentiation in vivo to encourage regeneration of the central nervous system.
Authors: Janine M Orban; Lorri B Wilson; Jessica A Kofroth; Mohammed S El-Kurdi; Timothy M Maul; David A Vorp Journal: J Biomed Mater Res A Date: 2004-03-15 Impact factor: 4.396
Authors: Sang-Moon Kang; Myung Soo Cho; Hyemyung Seo; Chul Jong Yoon; Sun Kyung Oh; Young Min Choi; Dong-Wook Kim Journal: Stem Cells Date: 2006-10-19 Impact factor: 6.277
Authors: Zin Z Khaing; Brian D Milman; Jennifer E Vanscoy; Stephanie K Seidlits; Raymond J Grill; Christine E Schmidt Journal: J Neural Eng Date: 2011-07-14 Impact factor: 5.379
Authors: Elisa Janine Gonzalez-Rothi; Angela M Rombola; Celeste A Rousseau; Lynne M Mercier; Garrett M Fitzpatrick; Paul J Reier; David D Fuller; Michael A Lane Journal: J Neurotrauma Date: 2015-05-05 Impact factor: 5.269
Authors: Sarah E Mondello; Michael D Sunshine; Amanda E Fischedick; Chet T Moritz; Philip J Horner Journal: J Neurotrauma Date: 2015-09-29 Impact factor: 5.269
Authors: Qinghua Xu; Jessica E Torres; Mazin Hakim; Paulina M Babiak; Pallabi Pal; Carly M Battistoni; Michael Nguyen; Alyssa Panitch; Luis Solorio; Julie C Liu Journal: Mater Sci Eng R Rep Date: 2021-07-30 Impact factor: 33.667
Authors: Andrew J Ciciriello; Dominique R Smith; Mary K Munsell; Sydney J Boyd; Lonnie D Shea; Courtney M Dumont Journal: ACS Biomater Sci Eng Date: 2020-09-14
Authors: Arshia Ehsanipour; Mayilone Sathialingam; Laila M Rad; Joseph de Rutte; Rebecca D Bierman; Jesse Liang; Weikun Xiao; Dino Di Carlo; Stephanie K Seidlits Journal: APL Bioeng Date: 2021-03-09